Cyclophosphamide and Hepatic neoplasm malignant - a phase IV clinical study of FDA data

Summary:

Hepatic neoplasm malignant is reported as a side effect among people who take Cyclophosphamide (cyclophosphamide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Prednisolone, and have Breast cancer.

The phase IV clinical study analyzes which people have Hepatic neoplasm malignant when taking Cyclophosphamide. It is created by eHealthMe based on reports of 185,094 people who have side effects when taking Cyclophosphamide from the FDA, and is updated regularly.

What is Cyclophosphamide?

Cyclophosphamide has active ingredients of cyclophosphamide. It is often used in multiple myeloma. eHealthMe is studying from 185,240 Cyclophosphamide users. Check the latest studies of Cyclophosphamide.

What is Hepatic neoplasm malignant?

Hepatic neoplasm malignant (liver cancer) is found to be associated with 395 drugs and 509 conditions by eHealthMe. Check the latest studies of Hepatic neoplasm malignant.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

185,094 people reported to have side effects when taking Cyclophosphamide.
Among them, 18 people (0.01%) have Hepatic neoplasm malignant.

Could Cyclophosphamide cause Hepatic neoplasm malignant?

Among these 18 people:

How long have people been on Cyclophosphamide when they have Hepatic neoplasm malignant? *

What is the gender of people who have Hepatic neoplasm malignant when taking Cyclophosphamide? *

female: 58.82 %
male: 41.18 %

What is the age of people who have Hepatic neoplasm malignant when taking Cyclophosphamide? *

What are other drugs people take besides Cyclophosphamide? *

What are other side effects people have besides Hepatic neoplasm malignant? *

Rashes (redness): 3 people, 16.67%
Weakness: 3 people, 16.67%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3 people, 16.67%
Thrombocytopenia (decrease of platelets in blood): 3 people, 16.67%
Mucosal Inflammation (infection of mucous membrane): 3 people, 16.67%
Nausea (feeling of having an urge to vomit): 3 people, 16.67%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 3 people, 16.67%
Abdominal Pain: 2 people, 11.11%
Hepatocellular Damage (liver damage): 2 people, 11.11%
White Blood Cell Count Decreased: 2 people, 11.11%

What are the existing conditions these people have? *

Wegener's Granulomatosis (inflammation of the blood vessels lungs sinuses): 2 people, 11.11%
Lymphoma (cancer that begins in immune system cells): 2 people, 11.11%
Hepatitis C: 2 people, 11.11%
Breast Cancer: 2 people, 11.11%
Thrombocytopenia (decrease of platelets in blood): 1 person, 5.56%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.56%
Osteoporosis (bones weak and more likely to break): 1 person, 5.56%
Leukaemia Relapse (failing of blood cancer or bone marrow cancer): 1 person, 5.56%
Immunodeficiency Disorders: 1 person, 5.56%
Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Cyclophosphamide and have Hepatic neoplasm malignant?

- Check whether Hepatic neoplasm malignant is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cyclophosphamide:

Cyclophosphamide (185,240 reports)

Browse all side effects of Cyclophosphamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatic neoplasm malignant:

Hepatic neoplasm malignant (395 drugs)

Browse all the conditions that are associated with Hepatic neoplasm malignant:

Hepatic neoplasm malignant (509 conditions)

Related publications that referenced our studies

Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .

How the study uses the data?

The study uses data from the FDA. It is based on cyclophosphamide (the active ingredients of Cyclophosphamide) and Cyclophosphamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.